Overview
Hsiang-yu Lin practices in Taiwan. Lin is highly rated in 19 conditions, according to our data. Their top areas of expertise are Mucopolysaccharidoses (MPS), Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome), Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), and Brachydactyly Mononen Type.
Their clinical research consists of co-authoring 136 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Distinguished
- Brachydactyly Mononen Type
- Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome)
- Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
- Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome)
- Mucopolysaccharidosis Type 4A (MPS IVA, Morquio Syndrome Type A)
- Advanced
- Aortic Regurgitation
- Beckwith-Wiedemann Syndrome
- Chromosome 6p Duplication
- Fabry Disease
- Hypotonia
- Kabuki Syndrome
- Experienced
- 15q11.2 Microdeletion
- Aortic Valve Stenosis
- Aplasia Cutis Congenita
- Atrial Septal Defect (ASD)
- Cardiofaciocutaneous Syndrome
- Cardiomyopathic Lentiginosis